Nanotechnology/Nanomedicines in Cancer Treatment

The application of nanotechnology to cancer treatment has some exciting potential consequences, including the possibility of eliminating cancerous tumours with little injury to healthy tissue and organs and the identification and removal of sick cells before they form tumours. Focused chemotherapy, which delivers a tumor-executing agent called tumour rot factor alpha (TNF) to developing tumours, is one form of treatment under investigation. TNF is attached to a gold nanoparticle together with Thiol-derivatized polyethylene glycol (PEG-THIOL), which hides the TNF-bearing nanoparticle from the resistant framework. This enables the nanoparticle to pass through the circulatory system unharmed.Delivering or Augmenting Radiotherapy.

  • Delivering Chemotherapy
  • Nano-enabled Immunotherapy

Related Conference of Nanotechnology/Nanomedicines in Cancer Treatment

July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
October 24-25, 2025

25th World Congress on Cancer and Diagnostics

Zurich, Switzerland
November 20-21, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain
December 08-09, 2025

13th Euro Breast Cancer and Therapeutics

Aix-en-Provence, France
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 23-24, 2026

16th World Congress on Breast Cancer Research & Therapies

Aix-en-Provence, France

Nanotechnology/Nanomedicines in Cancer Treatment Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in